AI-generated analysis. Always verify with the original filing.
Plus Therapeutics, Inc. furnished Item 2.02 under Form 8-K, announcing financial results via Exhibit 99.1 Press Release dated March 12, 2026. This disclosure provides investors with the company's latest earnings information.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K (including Exhibit 99.1) is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange A
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release Announcing Financial Results, dated March 12, 2026 104 Cover Page